Browsing by Author "Ozyigit, G."
Now showing 1 - 10 of 10
- Results Per Page
- Sort Options
Item Clinical Outcomes for Patients with Gleason Score 10 Prostate Adenocarcinoma: TROD 09-004 Study(2019) Ozyigit, G.; Onal, H.C.; Hurmuz, P.; iribas, A.; Cetin, I.; Gorken, I.B.; Yalman, D.; Akyol, F.Item Interpreting Clinical Parameters and Nomograms for Predicting Lymph Node Metastasis Detected with 68 Ga-PSMAPET/CT in prostate cancer patients(2020) Onal, C.; Ozyigit, G.; Oymak, E.; Guler, O.C.; Hurmuz, P.; Tilki, B.; Torun, N.; Tuncel, M.; Reyhan, M.; Caglar, M.; Yapar, A.F.; Akyol, F.; 0000-0001-8550-3368; 0000-0002-2742-9021; 0000-0003-1715-4180; 0000-0001-6908-3412; 0000-0002-5597-676X; AAJ-5242-2021; D-5195-2014; AAI-8973-2021; AAC-5654-2020; AAE-2718-2021Item Patterns of Recurrence and Survival Rates in Endometrial Cancer According to ESMO-ESGO-ESTRO Risk Classification(2018) Sari, S. Yuce; Gultekin, M.; Rahatli, S.; Altundag, O.; Turker, A.; Kars, A.; Yuce, K.; Ayhan, A.; Ozyigit, G.; Yildiz, F.; 0000-0003-3163-7429; 0000-0003-0197-6622; AAJ-3047-2021; W-9219-2019Item Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival Following Stereotactic Ablative Radiation Therapy in Oligometastatic Castration-Sensitive Prostate Cancer(2022) Sutera, P.; Deek, M. P.; Guler, O. C.; Hurmuz, P.; Reyhan, M.; Rowe, S.; Hrinivich, W. T.; Ren, L.; Song, D.; Kiess, A. P.; Oymak, E.; Pienta, K.; Pomper, M. G.; Feng, F. Y.; Ozyigit, G.; Tran, P. T.; Phillips, R.; Onal, C.Item Radiation Therapy Outcomes After Skin-Sparing Mastectomy and Implant-Based Breast Reconstruction(2016) Sari, S. Yuce; Kotek, A.; Gultekin, M.; Yildirim, B. Akkus; Onal, C.; Ozyigit, G.; Gurkaynak, M.; Yildiz, F.; https://orcid.org/0000-0001-6661-4185; V-5717-2017; HOC-5611-2023Item The Role of (68)ga-PSMA-PET/CT in Pelvic FIELD Delineation in Prostate Cancer Patients with Pelvic Lymph Node Metastasis(2019) Onal, C.; Hurmuz, P.; Torun, N.; Tuncel, M.; Guler, O. C.; Reyhan, M.; Caglar, M.; Ozyigit, G.; 0000-0001-6908-3412; AAC-5654-2020Item SBRT and Tyrosine Kinase Inhibitors in Patients with Oligometastatic Renal Cell Carcinoma(2023) Onal, C.; Oymak, E.; Guler, O. C.; Tilki, B.; Yavas, G.; Hurmuz, P.; Yavas, C.; Ozyigit, G.Item SBRT in patients with oligometastatic renal cell carcinoma: A multi-institutional analysis(2022) Guler, O. C.; Hurmuz, P.; Ozyigit, G.; Onal, C.Item The Treatment Outcomes of Oligometastatic Colorectal Cancer Patients Treated with Stereotactic Body Radiation Therapy: A Multi-Institutional Analysis TROD 02-008(2022) Guler, O. C.; Hurmuz, P.; Atalar, B.; Guney, Y. Yukselen; Saglam, E. K.; Akyurek, S.; Bolukbasi, Y.; Gural, Z.; Tugrul, F.; Korcum, A. F.; Sen, C. A.; Yildirim, B. Akkus; Oksuz, D. C.; Celik, O. Karakoyun; Kurt, M.; Guzeloz, Z.; Yavas, G.; Ozyigit, G.; Aksu, M. G.; Onal, C.; 0000-0001-9724-253X; 0000-0003-1043-8105; GNH-4101-2022; G-9920-2016Item Treatment Outcomes of Postoperative Ultra-Hypofractionated Stereotactic Body Radiotherapy in Prostate Cancer(2022) Ozyigit, G.; Onal, C.; Hurmuz, P.; Esen, S. Beduk; Tilki, B.